UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Medicinal Chemistry

Accelerating the Medicinal Chemistry Design Cycle

MedChemNet and Future Medicinal Chemistry editors Jasmine Harris and Ben Walden interviewed Emma Parmee from Merck & Co at the Global Medicinal Chemistry and GPCR Summit.

Read More

Optimising Targeted Protein Degradation

02MedChemNet and Future Medicinal Chemistry editors Jasmine Harris and Ben Walden interviewed George Burslem from Yale University at the Global Medicinal Chemistry and GPCR Summit.

Read More

Insights in Medicinal Chemistry and GPCR

MedChemNet and Future Medicinal Chemistry editors Jasmine Harris and Ben Walden share 5 key insights gained from the Global Medicinal Chemistry and GPCR Summit.

Read More

Reviewing the Global Medicinal Chemistry and GPCR Summit

MedChemNet and Future Medicinal Chemistry were thrilled to attend the Global Medicinal Chemistry and GPCR Summit, organised by Global Engage. The event shared the latest in medicinal chemistry and GPCR developments with delegates from across the globe. Represented at the summit were a number of large and small pharmaceutical companies, as well as biotechnology companies, CROs and academics.

Read More

Manhunting high-value targets in cancer combat

Cancer poses a formidable challenge to public health in modern society. In duelling rituals, the challenged party is usually given the choice of weapons, and possibilities are numerous. Knowing the weaknesses of your opponent is key to combat strategies and weapon selection.

Read More

Looking to the future of Medicinal Chemistry

What is the future of medicinal chemistry? Ahead of the executive panel discussion at the upcoming Global Medicinal Chemistry & GPCR Summit, we spoke to David Powell of Inception Sciences Canada about his work and his predictions for the future.

Read More

Are you looking for a faster horse in drug discovery?

Discovering and developing new drugs is difficult. Very difficult indeed. The cost of developing a new medicine, when you factor in the costs of all those projects which fail before getting to market, is increasing and is Very Large Indeed so what can be done to get us out of this situation?

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive